Surge in Deadly Brain Infection Cases Linked to Fungal Outbreak
A significant rise in infections caused by Cladophialophora bantiana poses serious health concerns, with experts seeking answers.
Cases of the brain-infecting fungus have surged, particularly since 2023.
The mortality rate for Cladophialophora bantiana is alarmingly high, affecting even those with healthy immune systems.
Research indicates a fourfold increase in infection rates from 2023 to 2025.
A concerning trend has emerged as cases of a rare but lethal fungal infection, Cladophialophora bantiana, have surged in recent years. According to a study conducted by scientists from the University of Washington and the Centers for Disease Control and Prevention (CDC), there has been a marked increase in reported cases, especially since the beginning of 2023. The precise mechanisms of infection remain elusive, complicating efforts to understand the reasons behind this alarming rise.
Fungal infections are typically uncommon in humans, and those that specifically target the brain are even rarer. Generally, such infections are secondary to other diseases affecting different parts of the body. However, Cladophialophora bantiana is unique in that it primarily targets the brain, leading to the formation of pus-filled pockets. Joshua Lieberman, a co-author of the study, noted that the mortality rate for this infection ranges between 60 and 70 percent, and it can affect individuals regardless of their immune status. Notably, nearly half of the patients diagnosed with this fungus had healthy immune systems.
The research team analyzed data from a specialized clinical reference laboratory at the University of Washington, which has documented confirmed cases of C. bantiana over several years. By comparing the frequency of positive samples to the total number of samples submitted for suspected fungal brain infections, they were able to identify a significant increase in cases. From January 2009 to July 2026, 48 confirmed cases and one probable case of C. bantiana were reported across 21 states and Washington, D.C. While one to five cases were detected annually from 2009 to 2023, the number sharply escalated in 2024 with eight cases, followed by 14 confirmed cases in 2025.
The study indicates that the rise in cases began around 2017 but became more pronounced in 2021. The average incidence of C. bantiana was 8.4 cases per 1,000 samples from 2017 to 2023, which saw a dramatic fourfold increase from 2023 to 2025. Despite its first identification in a brain abscess in 1911, much about this fungus remains a mystery, including its natural habitat and infection pathways. It is hypothesized that the fungus may enter the body through the skin or via inhalation before reaching the brain, but the exact route is still unconfirmed. The reasons why even healthy individuals are susceptible to this infection also remain unclear. Experts emphasize the need for systematic data collection to better understand the rising caseload and its implications for public health.


